Synthetic cannabinoids (often sold as Spice or K2) have become popular alternatives to cannabis due to easy access and portrayed safety.
Synthetic cannabinoids (often sold as Spice or K2) have become popular alternatives to cannabis due to easy access and portrayed safety. The first trial of its kind has looked at the neurocognitive and subjective experiences that occur after taking the synthetic cannabinoid JWH-018. The results are published in the British Journal of Pharmacology.
JWH-018 dosing resulted in drug concentrations that were generally low and not fully representative of common use, but initial impairments of neurocognitive function and subjective feelings of high did emerge.
Additional Information
Link to Study: http://onlinelibrary.wiley.com/doi/10.1111/bph.14066/full
About Journal
The British Journal of Pharmacology (BJP) is a broad-based journal giving leading international coverage of all aspects of experimental pharmacology. It publishes high quality original research and authoritative reviews.
Penny Smith
Tel: +44 (0)1243 770448
sciencenewsroom@wiley.com